Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Urinary Bladder Neoplasms × Registries × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Second Primary 1

Interventions

pembrolizumab 18 Gemcitabine 18 Cisplatin 15 Magnetic Resonance Spectroscopy 13 Specimen Handling 11 Cystectomy 10 Docetaxel 7 enfortumab vedotin 6 Mitomycin 6 Carboplatin 6 Standard of Care 5 Cystoscopy 5 durvalumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Practice Guidelines as Topic 4 sacituzumab govitecan 3 avelumab 3 Surveys and Questionnaires 3 Radiation 3 Nivolumab 3 Multiparametric Magnetic Resonance Imaging 3 Mitozytrex 3 tislelizumab 2 dehydroftorafur 2 cemiplimab 2 alvimopan 2 Therapeutic Uses 2 Surgical Procedures, Operative 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡